NCT05026502View on ClinicalTrials.gov

A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules

TerminatedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

October 5, 2021

Primary Completion Date

August 30, 2022

Study Completion Date

August 30, 2022

Conditions
Heavy Menstrual BleedingUterine Fibroids
Trial Locations (1)

27703

IQVIA RDS, Inc., Durham

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY

NCT05026502 - A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules | Biotech Hunter | Biotech Hunter